Yale University
耶鲁大学
Yale University appears in elsewhere's corpus primarily as a research origin for scientific founders and technical talent in Chinese VC-backed startups. Per a 2020 FreeS Fund piece, Professor Fan Rong of Yale developed the core single-cell analysis platform that became the foundation of Singleron Biotechnologies, a FreeS portfolio company focused on high-throughput sequencing . Yale biologist Frank Slack, who first discovered microRNA in humans in 2001, later served as scientific advisor for MiRXES, a cancer early-detection company covered by Gaorong Ventures in 2021 . The university also appears as a training ground for talent: Galaxy Pharma Tech's core team included Yale graduates among its ranks of MIT, Tsinghua and Peking University alumni, per a 2020 5Y Capital article , and Monolith Capital's 2026 profile of founder Lu Ziheng noted he went to Yale to learn experimental techniques before returning to Hong Kong to build his lab . The Yale-China Health Collaborative (YHCC) was also listed as a supporting organization for FreeS Fund's 2020 biomedical summit .
AI-generated — may contain errors, please verify.
Coverage
Tiangong Kaiwu: The Fifth Paradigm
A Material, An Industry
Monolith砺思资本·The "Pinduoduo" of M&A: A New Model of Entrepreneurship Built for Investors | Entering the Game
It was a hit in the US for three decades, but remains niche in China.
暗涌Waves·Floodgate founding partner Mike Maples' year-opening podcast: How to invest in the next 100x startup
Every great startup exists to build a future that is destined to arrive.
真格基金·A Conversation with Adam Tooze: How Venture Capital Reached Its Present Moment Through the Eyes of a Macroeconomist
Crises in this era tend to compound, yet remedies remain scarce.
暗涌Waves·"Tiny but Mighty" miRNA: How Cancer Can Be Caught at Its Earliest Stage | Gaorong Ventures "Future"
By applying microRNA to early cancer screening, we can transform cancer from a terminal illness into a chronic disease that can be intercepted at an early stage.
高榕创投·How Does the Fusion of Science and Art Spark Creativity? | 5Y View
Every artist is busy questioning and studying the world, just like a scientist.
五源资本·Li Feng: One Chart to Decode Biotech Innovation Opportunities | Your Complete Guide to the FreeS Fund 2020 Biomedical Summit
Three Livestreams and One Offline Symposium, Decoding the Era of Biomedical Innovation
峰瑞资本·The Collision of AI and Pharmaceuticals: Galaxy Pharma Tech Raises Nearly $10 Million in Funding | Light Moments
Galixir announced the completion of a nearly $10 million Pre-A funding round. The round was co-led by Source Code Capital and DCM, with 5Y Capital participating as a follow-on investor. Gaorong Capital, the lead investor in the company's angel round, continued to increase its stake.
五源资本·







